Gout Disease Directly Detected by GoutiFind™, New Non-Invasive Diagnostic Test from Boulder Diagnostics
In vitro diagnostics company also introduces SpiroFind® Vet for active Lyme Disease detection in dogs and horses
BOULDER, Colo. and MELLRICHSTADT, Germany, Oct. 18, 2013 /PRNewswire/ -- Boulder Diagnostics announces the European Market Launch of its CE marked GoutiFind™ in vitro diagnostic test for the detection of active Gout disease from whole blood. The GoutiFind™ test is offered throughout the EU as a diagnostic service by the company's clinical diagnostic service laboratory in Mellrichstadt, Germany. At the same time, the company announces the launch of the SpiroFind® Vet test for active Lyme disease in dogs and horses in the US and EU markets.
(Logo: http://photos.prnewswire.com/prnh/20131018/PH96450LOGO-a )
(Logo: http://photos.prnewswire.com/prnh/20131018/PH96450LOGO-b )
The GoutiFind™ test can detect active Gout disease from a simple blood sample without employing the unreliable determination of the uric acid level. It therefore provides a non-invasive reliable diagnosis of Gout disease. The GoutiFind™ test can replace the invasive joint puncture method for Gout detection and thus make reliable Gout diagnosis available to a much broader range of medical institutions and physician practices. The test is based on measuring the cellular immune response to a specific challenge with a Gout stimulus. The clinical effectiveness of diagnostic method of the GoutiFind™ test has been published in a peer reviewed journal. "The GoutiFind™ test simplifies and makes Gout diagnosis more broadly available," comments Dr. Wolfgang Pieken, CEO of Boulder Diagnostics Inc., and adds, "the GoutiFind™ test is the second product from our technology platform that queries the trained immunity for active disease."
"At our clinical laboratory in Mellrichstadt, Germany, we now accept whole blood samples for Gout detection by the GoutiFind™ method," states Dr. Anton Waldherr, laboratory physician of Boulder Diagnostics Europe GmbH.
The SpiroFind® Vet test for active Lyme disease in dogs and horses applies the same principle as the SpiroFind test for humans to the detection of Borrelia infection in those two animal species. The clinical laboratory in Boulder, CO is accepting whole blood samples from throughout the US. The clinical laboratory in Mellrichstadt, Germany is accepting whole blood samples from throughout the EU.
Editor's note
For further information, please contact:
Wolfgang Pieken, CEO, Boulder Diagnostics Inc
6395 Gunpark Drive Ste W – Boulder, CO 80301, USA
Phone +1 720.897.6276 – Email
www.boulderdiagnostics.com
EU ordering:
For ordering a GoutiFind™ test or SpiroFind® Vet test please contact:
Jana Hummel, Boulder Diagnostics Europe GmbH
Stockheimer Strasse 12 – D-97638 Mellrichstadt, Germany
Phone: +49 9776 709 3488 – Email
www.boulderdiagnostics.com
US ordering:
For ordering a SpiroFind® Vet test please contact:
Dede Willis, Boulder Diagnostics US LLC
6395 Gunpark Dr. Ste. W – Boulder, CO 80301
Phone: (720) 897-6276 – Email
www.boulderdiagnostics.com
About Boulder Diagnostics
Boulder Diagnostics Inc. is an in vitro diagnostics company that focuses on identifying, developing, and marketing new diagnostics tests for underserved markets. In addition to Gout disease diagnostics, Boulder Diagnostics currently offers the SpiroFind® test for active Lyme disease and the ParaFlor® test for rapid detection of parasitic disease.
Read more news from Boulder Diagnostics
SOURCE Boulder Diagnostics
Share this article